Evaluation of Coronary Flow Reserve in Patients with Left Coronary Artery Disease and with Syndrome X by Transesophageal Echocardiography

张薇,白晨,张运,李继福,李贵双,葛志明,季小平
DOI: https://doi.org/10.3969/j.issn.1001-1439.2002.01.009
2002-01-01
Journal of Clinical Cardiology
Abstract:Objective: To evaluate coronary flow reserve (CFR) in patients with left coronary artery disease and with syndrome X. Method:Transesophageal echocardiography were performed in 15 control subjects, 10 patients with 70% left anterior descending coronary artery (LAD) stenosis, 6 patients with 30%~60% LAD stenosis and 7 patients with syndrome X. The peak diastolic coronary flow velocity (PVD) was recorded in the proximal part of the left descending artery with use of pulsed Doppler guided by color flow imaging before and after an intravenous dipyridamole infusion ( 0.56 mg/kg in 4 min ). CFR was calculated as the ratio of the dipyridamole to rest PVD (D/R PDV).Result:Doppler parameters were not significantly different in all groups at baseline. Increase in PVD was significantly lower in patients with coronary artery disease and syndrome X compared with control patients after dipyridamole administration. D/R PDV was ( 1.55 ± 0.43 ) cm/s in patients with severe coronary artery disease, ( 2.62 ± 0.71 ) cm/s in those with less severe disease and ( 2.19 ± 0.36 ) cm/s in patients with syndrome X, which was significantly lower than D/R PDV of ( 3.43 ± 0.62 ) cm/s found in control group (P 0.05 ~ 0.001 ). Furthermore, D/R PDV was lower in patients with severe coronary artery disease than that in patients with less severe disease and with syndrome X (P 0.05 ~ 0.01 ). As a result D/R PDV was corelated with coronary artery stenosis (r= 0.83 ,P 0.001 ). Conclusion:CFR calculated by TEE is a feasible and reliable method. CFR can be used for noninvasive evaluation of patients with syndrome X and patients with severe left coronary artery disease.
What problem does this paper attempt to address?